tiprankstipranks
KalVista appoints Jeb Ledell as COO
PremiumThe FlyKalVista appoints Jeb Ledell as COO
2M ago
KalVista price target lowered to $33 from $35 at JonesResearch
Premium
The Fly
KalVista price target lowered to $33 from $35 at JonesResearch
2M ago
KalVista Pharmaceuticals Reports Progress in HAE Treatment
Premium
Company Announcements
KalVista Pharmaceuticals Reports Progress in HAE Treatment
2M ago
KalVista enters synthetic royalty financing with DRI Healthcare Trust
PremiumThe FlyKalVista enters synthetic royalty financing with DRI Healthcare Trust
3M ago
KalVista Secures $184M Financing for Sebetralstat Launch
Premium
Company Announcements
KalVista Secures $184M Financing for Sebetralstat Launch
3M ago
KalVista 5.5M share Secondary priced at $10.00
Premium
The Fly
KalVista 5.5M share Secondary priced at $10.00
3M ago
KalVista Pharmaceuticals Welcomes New CFO for Future Growth
PremiumCompany AnnouncementsKalVista Pharmaceuticals Welcomes New CFO for Future Growth
5M ago
KalVista names Brian Piekos as CFO
Premium
The Fly
KalVista names Brian Piekos as CFO
5M ago
KalVista presents sebetralstat data at Bradykinin Symposium 2024
Premium
The Fly
KalVista presents sebetralstat data at Bradykinin Symposium 2024
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100